Showing results (101-110 of 111) with videos related to
Sort By:
Pageof 12
Cellular Immunology|March 1, 1986
The relationship of abnormalities of cellular immunity to antibodies to HTLV-III in homosexual menB S Dobozin, F N Judson, D L Cohn, et al.The New England Journal of Medicine|February 25, 1988
Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibodyJ W Ward, S D Holmberg, J R Allen, et al.The New England Journal of Medicine|September 16, 1993
Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDSS D Nightingale, D W Cameron, F M Gordin, et al.JAMA|April 1, 1992
Spectrum of disease in persons with human immunodeficiency virus infection in the United StatesK M Farizo, J W Buehler, M E Chamberland, et al.The New England Journal of Medicine|June 6, 1998
Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance SurveillanceA Pablos-Méndez, M C Raviglione, A Laszlo, et al.Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 3, 1998
Size and duration of zidovudine benefit in 1003 HIV-infected patients: U.S. Army, Navy, and Air Force natural history data. Military Medical Consortium for Applied Retroviral ResearchL I Gardner, S H Harrison, C W Hendrix, et al.American Journal of Respiratory and Critical Care Medicine|November 1, 1996
The impact of human immunodeficiency virus infection on drug-resistant tuberculosisF M Gordin, E T Nelson, J P Matts, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 1998
Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG)W M el-Sadr, D C Perlman, J P Matts, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 5, 1999
A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDSD L Cohn, E J Fisher, G T Peng, et al.The Journal of Infectious Diseases|April 14, 2000
Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol TeamC A Benson, P L Williams, D L Cohn, et al.Pageof 12